Data / Form D filings / INVIRAGEN, INC.
INVIRAGEN, INC.: Form D filings
INVIRAGEN, INC., a biotechnology company in Fort Collins, CO, filed 4 Form D notices with the SEC between 2009 and 2012. The latest, on January 24, 2012, reports $15.3 million sold of a $15.3 million offering to 24 investors.
Find out what INVIRAGEN, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1613 PROSPECT PARKWAY, SUITE 100, Fort Collins, CO, 80525
- Phone
- (970) 672-4918
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1461681
The full lists. Form D filings in Colorado: 1,787 rows, $89.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 24, 2012 | Amendment | $15,307,459 | $15,307,459 | $0 | 24 | Sep 22, 2009 | sec.gov |
| Oct 8, 2010 | Amendment | $15,307,459 | $9,852,914 | $5,454,545 | 24 | Sep 22, 2009 | sec.gov |
| Oct 6, 2009 | New notice | $2,237,186 | $2,237,186 | $0 | 2 | Sep 22, 2009 | sec.gov |
| Oct 6, 2009 | New notice | $15,307,459 | $4,398,369 | $10,909,090 | 24 | Sep 22, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| JORGE OSORIO | Executive Officer, Promoter | |
| HENG TONG CHOO | Director | |
| DAN STINCHCOMB | Executive Officer, Director, Promoter | |
| JOHN TONG NEIS | Director | |
| FRED TONG SCHWARZER | Director |
Other biotechnology companies in Colorado that filed recently
- HealthVest Fund V LLC offering · Nov 5, 2026
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
Every Form D from the week of Jan 23, 2012 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what INVIRAGEN, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.